Speaker: Ian Tannock

0:03:38

Highlighting problems in personalized medicine

0:03:57

The disadvantages of randomised clinical trials

0:03:17

Limitations of precision medicine to be addressed

0:02:38

The thinking behind precision medicine for cancer therapy

0:01:14

Presenting your research – practical advice

1:03:56

Do we need Phase 3 trials in oncology?

1:20:45

What to look out for when reading a clinical trial report? A primer on critical appraisal skills.

0:54:29

ACReC Session 4 -- How to Stimulate Earlier Diagnosis Through Research -- July 16, 2021

1:21:56

ACReC Session 6 -- Conducting Clinical Research on Drugs Developed by Pharma -- July 30, 2021

0:51:51

ACReC Session 1 -- Epidemiology of Cancer in Africa -- June 25, 2021

2:21:01

12th Annual Symposium on Global Cancer Research: Early Career Investigator Day 1

1:03:13

Which medicines should be used in cancer care? by Nathan I Cherny, MBBS, FRACP, FRCP

0:01:21

Anthea McINTYRE MEP on better law-making agreement

1:00:17

'Thinking outside the box in clinical trial design' EORTC-MAC Joint Webinar Oct 6, 2021

2:26:55

Session 1: Overview - Current Challenges to the Delivery of Affordable Cancer Care

0:57:09

ACReC Session 5 -- Improving Palliative Care Through Research -- July 9, 2021

1:00:25

CWMGR: Patients Improved Cancer Outcomes – But Miles to Go Before We Sleep

0:01:25

Former Taoiseach Bertie Ahern on the Good Friday Agreement post-Brexit

0:01:45

Debating Europe's response to the refugee crisis

2:17:29

Utility of Molecular Profiling

1:28:28

Water: Pollute or Recycle, a Community Decision?

0:01:16

Protecting national habitat is a national responsibility - Julia Reid MEP

1:03:59

KTMW 'Beyond the Battlefield' talk: John Tannock talk 13 April 24

0:45:29

Master class 2010: Metastatic disease management: Dr Lisa M Pickering